Nasdaq:ACHC
Acadia Healthcare Company, Inc.
A US-based behavioral health provider delivering residential and outpatient care solutions for substance use and mental health conditions.
Key Metrics
Investment Thesis
Bull Case
Acadia Healthcare benefits from secular tailwinds in behavioral health demand which remains elevated post-pandemic, supported by a robust network of facilities and experienced clinical teams. The company's ability to expand its footprint through organic growth and strategic acquisitions while maintaining positive operating cash flow provides a platform for long-term value creation despite current profitability challenges.
Bear Case
The massive net loss of $1.09B in 2025 alongside a significant retained earnings deficit of $765.8M raises serious concerns about the sustainability of current business models and pricing power. Heavy capital expenditures of $571.8M coupled with substantial debt levels of $2.47B long-term debt create financial leverage risks that could be exacerbated by any further regulatory changes or payer reimbursement cuts.
About Acadia Healthcare Company, Inc.
Acadia Healthcare Company provides comprehensive behavioral health services through its Acadia Behavioral Health network, serving patients across residential treatment centers, intensive outpatient programs, and specialty care clinics primarily in the United States. The company focuses on treating substance use disorders, mental illness, and co-occurring conditions using a multi-disciplinary approach including medication management and therapy.
Analysis
Management Discussion
While revenue grew steadily from $2.61B in 2022 to $3.31B in 2025, net income deteriorated sharply from a profit of $280M in 2022 to a loss of $1.09B in 2025, reflecting increased operating expenses and potentially one-time charges or impairment costs. The company maintained positive cash flow from operations at $131.9M despite the large capital expenditure outflow of $571.8M, suggesting ongoing investment in facility infrastructure or acquisitions that are currently depressing profitability.
Industry Overview
The US behavioral health industry is experiencing robust growth driven by increasing prevalence of mental health disorders and substance use, creating significant demand for residential and outpatient treatment services. Regulatory environments continue to evolve with parity laws expanding access but also imposing stricter compliance requirements that impact operational efficiency and profit margins across the sector.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $2.61B | $2.93B | $3.15B | $3.31B |
| Cost of Revenue | $0 | $0 | $0 | $0 |
| Gross Profit | $2.61B | $2.93B | $3.15B | $3.31B |
| Operating Expenses | $2.24B | $2.95B | $2.81B | $4.38B |
| Operating Income | $374.1M | $-25.4M | $341.9M | $-1.07B |
| G&A | $124.3M | $153.3M | $156.8M | $177.6M |
| Stock-Based Comp | $29.6M | $32.3M | $37.1M | $31.7M |
| D&A | $117.8M | $132.3M | $149.6M | $189.2M |
| Depreciation | $117.8M | $132.3M | $149.6M | $189.2M |
| Other OpEx | $2.11B | $2.80B | $2.66B | $4.20B |
| Non-Operating Income | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $374.1M | $-25.4M | $341.9M | $-1.07B |
| Income Tax | $94.1M | $-9.7M | $77.4M | $26.0M |
| Continuing Ops | $280.0M | $-15.7M | $264.5M | $-1.09B |
| Discontinued Ops | $0 | $0 | $0 | $0 |
| Net Income | $280.0M | $-15.7M | $264.5M | $-1.09B |
| Minority Interest | $6.9M | $6.0M | $8.9M | $10.8M |
| Net to Common | $273.1M | $-21.7M | $255.6M | $-1.10B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Current Assets | $506.1M | $596.0M | $577.5M | $814.1M |
| Cash & Equivalents | $97.6M | $100.1M | $76.3M | $133.2M |
| Accounts Receivable | $322.4M | $361.5M | $365.3M | $440.6M |
| Inventory | $5.1M | $5.3M | $5.7M | $5.7M |
| Other Current Assets | $81.0M | $129.2M | $130.2M | $234.6M |
| Long-Term Assets | $4.48B | $4.76B | $5.38B | $4.71B |
| PP&E (Net) | $1.95B | $2.27B | $2.85B | $3.11B |
| Intangibles | $76.0M | $73.3M | $70.0M | $96.7M |
| Goodwill | $2.22B | $2.23B | $2.26B | $1.30B |
| Operating Leases | $135.2M | $117.8M | $118.4M | $134.0M |
| Other LT Assets | $95.6M | $79.2M | $73.0M | $75.1M |
| Total Assets | $4.99B | $5.36B | $5.96B | $5.53B |
| Current Liabilities | $388.3M | $885.8M | $577.9M | $525.2M |
| Accounts Payable | $104.7M | $156.1M | $232.7M | $150.4M |
| Current Debt | $21.2M | $29.2M | $76.8M | $28.4M |
| Current Leases | $26.5M | $26.3M | $25.5M | $21.2M |
| Deferred Revenue | $6.7M | $2.2M | $1.7M | $2.8M |
| Other Current Liab | $229.2M | $672.0M | $241.3M | $322.4M |
| Long-Term Liabilities | $1.70B | $1.59B | $2.19B | $2.86B |
| Long-Term Debt | $1.36B | $1.34B | $1.88B | $2.47B |
| LT Operating Leases | $116.4M | $100.8M | $101.8M | $122.0M |
| Other LT Liab | $217.6M | $142.0M | $206.2M | $268.2M |
| Total Liabilities | $2.09B | $2.47B | $2.77B | $3.39B |
| Shareholders' Equity | $2.90B | $2.89B | $3.19B | $2.14B |
| Retained Earnings | $153.4M | $131.7M | $387.3M | $-765.8M |
| Total L&E | $4.99B | $5.36B | $5.96B | $5.53B |
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net Income (CFO) | $280.0M | $-15.7M | $264.5M | $-1.09B |
| Non-Cash Adjustments | $16.1M | $404.1M | $252.6M | $965.4M |
| Working Capital Changes | $84.4M | $73.9M | $-387.3M | $258.4M |
| Cash from Operations | $380.6M | $462.3M | $129.7M | $131.9M |
| Capital Expenditures | $296.1M | $424.1M | $690.4M | $571.8M |
| Cash from Investing | $-305.8M | $-397.2M | $-736.5M | $-556.2M |
| Debt Issuances | — | — | $350.0M | $1.20B |
| Share Buybacks | — | — | — | $50.0M |
| Cash from Financing | $-110.9M | $-62.7M | $583.0M | $481.3M |
| FX Effect | $0 | $0 | $0 | $0 |
| Net Change in Cash | $-36.2M | $2.4M | $-23.8M | $56.9M |
| Beginning Cash | $133.8M | $97.6M | $100.1M | $76.3M |
| Ending Cash | $97.6M | $100.1M | $76.3M | $133.2M |
Frequently Asked Questions
How does Acadia Healthcare Company, Inc. make money?
Primary revenue streams include Residential Treatment Services offering 24/7 inpatient care, Intensive Outpatient Programs providing structured therapy schedules, Specialty Care Clinics for medication-assisted treatment, and other ancillary services such as primary care and diagnostic testing integrated into the patient journey.
What are the main risks for ACHC?
Significant regulatory headwinds from the Mental Health Parity and Addiction Equity Act impacting reimbursement rates and coverage scope; persistent workforce shortages in behavioral health leading to recruitment costs and potential service disruptions; high capital intensity required for facility expansion and maintenance affecting free cash flow generation; sensitivity to economic downturns reducing demand for non-essential outpatient services.
What is ACHC's competitive advantage?
Extensive geographic footprint with over 80 locations allows for regional density and referral network strength; high operating margins driven by proprietary clinical models and specialized nursing staff retention; diversified payer mix including Medicare, Medicaid, and commercial insurance reducing reliance on any single reimbursement source.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.